Oppenheimer Re-its Outperform for Innophos Holdings (IPHS)

Oppenheimer analysts Edward Yang and Luis Amadeo reiterated their Outperform rating for Innophos Holdings

. Innophos Holdings is a chemical company, producing primarily phosphates. Oppenheimer summarized, "After our meeting with IPHS, we continue to see the stock as a compelling investment at 8.0x '11E trough EPS, with pricing and volume growth intact. As an added benefit, despite a large Latin American presence, IPHS's sales are dollar-based, so the company has virtually no F/X risk or exposure to the flagging euro." The analysts' 12-18 month price target is $42.00. IPHS is currently trading at $25.20.